George Farmer
Stock Analyst at Scotiabank
(1.80)
# 3,112
Out of 4,865 analysts
75
Total ratings
30.95%
Success rate
-6.69%
Average return
Main Sectors:
Top Industries:
Stocks Rated by George Farmer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| URGN UroGen Pharma | Maintains: Sector Outperform | $23 → $47 | $13.24 | +254.98% | 1 | Jun 13, 2025 | |
| ACLX Arcellx | Maintains: Sector Outperform | $133 → $93 | $62.88 | +47.90% | 2 | May 9, 2025 | |
| SNDX Syndax Pharmaceuticals | Maintains: Sector Perform | $16 → $17 | $9.64 | +76.35% | 4 | May 6, 2025 | |
| TARA Protara Therapeutics | Initiates: Sector Outperform | $12 | $3.06 | +292.16% | 1 | Apr 16, 2025 | |
| TPST Tempest Therapeutics | Downgrades: Sector Perform | $91 → $9 | $6.85 | +31.39% | 4 | Apr 10, 2025 | |
| ADAP Adaptimmune Therapeutics | Maintains: Sector Outperform | $3.15 → $1.4 | $0.26 | +446.23% | 2 | Mar 21, 2025 | |
| JANX Janux Therapeutics | Maintains: Sector Perform | $62 → $41 | $22.91 | +78.96% | 4 | Feb 28, 2025 | |
| NAMS NewAmsterdam Pharma Company | Maintains: Sector Outperform | $47 → $52 | $18.49 | +181.23% | 4 | Feb 27, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Sector Perform | $78 → $80 | $55.00 | +45.45% | 8 | Feb 20, 2025 | |
| BIIB Biogen | Maintains: Sector Outperform | $244 → $224 | $126.56 | +76.99% | 3 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $102 | $26.43 | +285.93% | 1 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $14 → $12 | $9.12 | +31.58% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $22 → $23 | $6.87 | +234.79% | 2 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $18 → $10 | $6.20 | +61.29% | 2 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Sector Outperform | $439 → $715 | $540.71 | +32.23% | 5 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $20 → $23 | $6.19 | +271.87% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $20 | $2.07 | +866.18% | 1 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $21 → $41 | $2.90 | +1,313.79% | 3 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $70 → $76 | $34.70 | +119.02% | 4 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $13 | $2.71 | +379.70% | 1 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $109 | $25.55 | +326.61% | 3 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $94 → $87 | $68.81 | +26.44% | 5 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $1.49 | +2,114.77% | 1 | Oct 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $40 | $0.77 | +5,111.73% | 1 | Jul 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $20 → $27 | $41.36 | -34.71% | 3 | May 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $89 → $75 | $128.23 | -41.51% | 3 | Apr 29, 2020 |
UroGen Pharma
Jun 13, 2025
Maintains: Sector Outperform
Price Target: $23 → $47
Current: $13.24
Upside: +254.98%
Arcellx
May 9, 2025
Maintains: Sector Outperform
Price Target: $133 → $93
Current: $62.88
Upside: +47.90%
Syndax Pharmaceuticals
May 6, 2025
Maintains: Sector Perform
Price Target: $16 → $17
Current: $9.64
Upside: +76.35%
Protara Therapeutics
Apr 16, 2025
Initiates: Sector Outperform
Price Target: $12
Current: $3.06
Upside: +292.16%
Tempest Therapeutics
Apr 10, 2025
Downgrades: Sector Perform
Price Target: $91 → $9
Current: $6.85
Upside: +31.39%
Adaptimmune Therapeutics
Mar 21, 2025
Maintains: Sector Outperform
Price Target: $3.15 → $1.4
Current: $0.26
Upside: +446.23%
Janux Therapeutics
Feb 28, 2025
Maintains: Sector Perform
Price Target: $62 → $41
Current: $22.91
Upside: +78.96%
NewAmsterdam Pharma Company
Feb 27, 2025
Maintains: Sector Outperform
Price Target: $47 → $52
Current: $18.49
Upside: +181.23%
BioMarin Pharmaceutical
Feb 20, 2025
Maintains: Sector Perform
Price Target: $78 → $80
Current: $55.00
Upside: +45.45%
Biogen
Feb 13, 2025
Maintains: Sector Outperform
Price Target: $244 → $224
Current: $126.56
Upside: +76.99%
Feb 13, 2025
Initiates: Sector Outperform
Price Target: $102
Current: $26.43
Upside: +285.93%
Feb 12, 2025
Maintains: Sector Outperform
Price Target: $14 → $12
Current: $9.12
Upside: +31.58%
Feb 11, 2025
Maintains: Sector Outperform
Price Target: $22 → $23
Current: $6.87
Upside: +234.79%
Jan 8, 2025
Maintains: Sector Perform
Price Target: $18 → $10
Current: $6.20
Upside: +61.29%
Nov 5, 2024
Upgrades: Sector Outperform
Price Target: $439 → $715
Current: $540.71
Upside: +32.23%
Oct 18, 2024
Maintains: Sector Outperform
Price Target: $20 → $23
Current: $6.19
Upside: +271.87%
Sep 30, 2024
Initiates: Sector Outperform
Price Target: $20
Current: $2.07
Upside: +866.18%
Sep 27, 2024
Maintains: Sector Outperform
Price Target: $21 → $41
Current: $2.90
Upside: +1,313.79%
Aug 12, 2024
Maintains: Sector Outperform
Price Target: $70 → $76
Current: $34.70
Upside: +119.02%
Mar 14, 2024
Initiates: Sector Outperform
Price Target: $13
Current: $2.71
Upside: +379.70%
Nov 17, 2020
Downgrades: Market Perform
Price Target: $109
Current: $25.55
Upside: +326.61%
Nov 6, 2020
Maintains: Market Perform
Price Target: $94 → $87
Current: $68.81
Upside: +26.44%
Oct 27, 2020
Initiates: Outperform
Price Target: $33
Current: $1.49
Upside: +2,114.77%
Jul 20, 2020
Initiates: Outperform
Price Target: $40
Current: $0.77
Upside: +5,111.73%
May 6, 2020
Maintains: Market Perform
Price Target: $20 → $27
Current: $41.36
Upside: -34.71%
Apr 29, 2020
Maintains: Outperform
Price Target: $89 → $75
Current: $128.23
Upside: -41.51%